Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) | Respiratory Research | Full Text
Survival analysis - Wikipedia
Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
The Arts, Sciences and Medicine: Progression Free Survival (PFS)
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors - Matthew Lei, Angela Michael, Seema Patel, Ding Wang, 2019
Cancers | Free Full-Text | Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC
